Intra-Cellular Therapies Inc. buy melinda
Start price
30.08.17
/
50%
€16.35
Target price
27.12.17
€22.55
Performance (%)
-14.01%
End price
27.12.17
€14.06
Summary
This prediction ended on 27.12.17 with a price of €14.06. The price of Intra-Cellular Therapies Inc. has decreased during the runtime of the prediction. Compared to the start price this resulted in a performance of -14.01%. melinda has 50% into this predictionPerformance without dividends (%)
Name | 1w | 1m | 1y | 3y |
---|---|---|---|---|
Intra-Cellular Therapies Inc. | 0.758% | 0.758% | 36.691% | 105.882% |
iShares Core DAX® | -1.114% | 5.062% | 24.922% | 25.215% |
iShares Nasdaq 100 | 1.816% | 9.828% | 29.548% | 44.324% |
iShares Nikkei 225® | 2.113% | 8.218% | 22.231% | 12.395% |
iShares S&P 500 | 2.038% | 7.448% | 30.358% | 43.899% |
Comments by melinda for this prediction
In the thread Intra-Cellular Therapies Inc. diskutieren
Therapien
ITCI auf dem richtigen Weg für die Einreichung der NDA bis Mitte 2018
(Vom Mitglied beendet)
Stopped prediction by melinda for Intra-Cellular Therapies Inc.
Intra-Cellular Therapies Inc.
Start price
Target price
Perf. (%)
€11.81
04.04.19
04.04.19
€18.04
04.11.21
04.11.21
233.36%
05.11.21
05.11.21
Intra-Cellular Therapies Inc.
Start price
Target price
Perf. (%)
€18.13
30.08.17
30.08.17
€25.00
27.12.17
27.12.17
-14.01%
27.12.17
27.12.17